About 1,838,622 results

Comparative computational analysis of SARS-CoV-2 nucleocapsid protein epitopes in taxonomically related coronaviruses

Animal-based food systems are unsafe: SARS-CoV-2 fosters the debate on meat consumption

New and emerging medical therapies in Parkinson’s disease

Quest Diagnostics SARS-CoV-2 RNA, Qualitative Real-Time RT-PCR

Rapid Decay of Anti–SARS-CoV-2 Antibodies in Persons with Mild Covid-19

An mRNA Vaccine against SARS-CoV-2 — Preliminary Report

Covid-19: Managing the Surge

As Covid-19 spreads around the world, health care leaders and clinicians currently dealing with rising case rates can learn much from those organizations hit with earlier surges of infection. NEJM Catalyst has featured articles, case studies, and conversations since the early days of the pandemic on the many dierent approaches and solutions to the problems posed by the SARS-CoV-2 virus. Th...

COVID-19 and Food Safety: Risk Management and Future Considerations

COVID-19, also known as the “novel coronavirus disease 2019,” is a respiratory illness, and the causative pathogen is officially named as “SARS-CoV-2.” Infections with SARS-CoV-2 have now been amplified to a global pandemic—as of April 3, 2020, nearly 1 018 000 cases have been confirmed in more than 195 countries, including more than 300 000 cases within the United States. Public safety guideli...

Lung ultrasound monitoring in patients with COVID-19 on home isolation

Many patients with COVID-19, the clinical illness caused by SARS-CoV-2 infection, exhibit mild symptoms and do not require hospitalization. Instead, these patients are often referred for 14-days of home isolation as symptoms resolve. Lung ultrasound is well-established as an important means of evaluating lung pathology in patients in the emergency department and in intensive care units. Ultraso...

COVID-19 and the potential long-term impact on antimicrobial resistance

The emergence of the Severe Acute Respiratory Syndrome coronavirus 2 (SARS-CoV-2) has required an unprecedented response to control the spread of the infection and protect the most vulnerable within society. Whilst the pandemic has focused society on the threat of emerging infections and hand hygiene, certain infection control and antimicrobial stewardship policies may have to be relaxed. It is...

The novel coronavirus 2019 (2019-nCoV) uses the SARS-coronavirus receptor ACE2 and the cellular protease TMPRSS2 for entry into target cells

Update Alert 2: Risks and Impact of Angiotensin-Converting Enzyme Inhibitors or Angiotensin-Receptor Blockers on SARS-CoV-2 Infection in Adults

Fomite transmission and disinfection strategies for SARS-CoV-2 and related viruses

Masks Do More than Protect Others during COVID-19: Reducing the Inoculum of SARS-CoV-2

Transmission of SARS-CoV-2: implications for infection prevention precautions

The dynamics of humoral immune responses following SARS-CoV-2 infection and the potential for reinfection

SARS-CoV-2 infection induces robust, neutralizing antibody responses that are stable for at least three months

Longitudinal evaluation and decline of antibody responses in SARS-CoV-2 infection

SNL-NM 2019 nCoV Real-Time RT-PCR Diagnostic Assay - Letter of Authorization

Qualitative detection of nucleic acid from SARS-CoV-2 in upper respiratory specimens (including nasopharyngeal swab, anterior nasal swab, mid-turbinate nasal swab and oropharyngeal swab, nasal washes, nasal aspirates) and bronchoalveolar lavage specimens from individuals suspected of COVID-19 by their healthcare provider.

Lilly SARS-CoV-2 Assay - Letter of Authorization

Qualitative detection of nucleic acid from SARS-CoV-2 in nasopharyngeal swabs, oropharyngeal (throat) swabs, anterior nasal swabs, mid-turbinate nasal swabs, nasal aspirates, nasal washes and bronchoalveolar lavage (BAL) fluid from individuals suspected of COVID-19 by their healthcare provider.